SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022)

Advanced breast cancer represents a challenge for patients and for physicians due its dynamic genomic changes yielding to a resistance to treatments. The main goal is to improve quality of live and survival of the patients through the most appropriate subsequent therapies based on the knowledge of the natural history of the disease. In these guidelines, we summarize current evidence and available therapies for the medical management of advanced breast cancer.

Automated summary

Advanced breast cancer poses challenges for patients and physicians due to the genomic changes that lead to treatment resistance. The primary goal is to enhance patients' quality of life and survival through appropriate subsequent therapies based on understanding the disease's natural progression. These guidelines provide a summary of the current evidence and available medical management options for advanced breast cancer.